A. Salahudeen et al., CISPLATIN INDUCES N-ACETYL CYSTEINE SUPPRESSIBLE F-2-ISOPROSTANE PRODUCTION AND INJURY IN RENAL TUBULAR EPITHELIAL-CELLS, Journal of the American Society of Nephrology, 9(8), 1998, pp. 1448-1455
In the low intracellular chloride milieu, chloride ions of cisplatin m
ay exchange for cellular SH moieties resulting in glutathione depletio
n, H2O2 accumulation, and lipid peroxidation, Cisplatin-induced lipid
peroxidation, in addition to causing direct cellular injury, may furth
er contribute to cisplatin-induced renal dysfunction by generating vas
oconstrictive E-2- and F-2-isoprostanes. The aim of this study was to
determine whether cisplatin-induced renal epithelial (LLC-PK1 and prim
ary human proximal tubular) cell injury is associated with increased p
roduction of isoprostanes, and whether this can be suppressed with a t
hiol donor, N-acetyl cysteine. It was confirmed that incubation of ren
al epithelial cells with cisplatin resulted in N-acetyl cysteine-inhib
itable glutathione depletion, H2O2 accumulation, Lipid degradation, an
d lactate dehydrogenase release. In additional experiments, incubation
of cells with cisplatin for 48 h was accompanied by a dose-related in
crease in total (free plus esterified) F-2-isoprostanes. An increase i
n F-2-isoprostanes was discernible at 16.5 mu M cisplatin and doubled
at 66.0 mu M. N-Acetyl cysteine at 50 mu M concentration effectively s
uppressed 66.0 mu M cisplatin-induced increase in isoprostanes. Simila
r findings were also obtained in human cells. Thus, cisplatin-induced
tubular cell injury is accompanied by increased isoprostane production
through a mechanism involving thiol depletion. On the basis of this n
ew finding, it is hypothesized that these arachidonic acid peroxidatio
n products may be partially responsible for the cisplatin-induced rena
l vasoconstriction demonstrable in the in vivo models.